feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
INVEST IN FUNDS
Active Biotech: Positive Phase I Results
Research Note
2023-01-30
08:52
Redeye raises its Base Case slightly following the positive conclusion of the phase I trial with laquinimod.
Richard Ramanius
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans